BUY IPCA Laboratories Limited — Siddharth Rai Mangala

bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))25 Sept 2026via Zee Business (Live)

Entry₹2,020Inferred
Target₹2,060
Total upside +1.98% (call closed)
Stop loss₹1,970-2.48% risk
Exit₹1,970Stop-loss hit — time not yet verified
Stop-loss hit-2.48%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Sept, 2:16 pm IST
4 supporting1 opposing
Supports the BUY call (4)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·24 Sept · today

Ipca Laboratories Reports Strong Q3FY26 Results with 11% Revenue Growth

NewsGoogle News·20 Sept · 5d ago

(opens in new tab)

Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits

NewsGoogle News·16 Sept · 1w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·18 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·25 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.